Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Oxidized resorbable cellulose (Gelita-cel) causing foreign body reaction in the mediastinum

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Social and emotional factors as predictors of poor outcomes following cardiac surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. What is the optimal level of suction on digital chest drainage devices following pulmonary lobectomy?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Preoperative pulmonary function in all comers for cardiac surgery predicts mortality†

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Functional recovery after discharge in enhanced recovery video-assisted thoracoscopic lobectomy: a pilot prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Simulation-based VATS resection of the five lung lobes: a technical skills test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Is complex segmentectomy safe?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Different types of oxidized cellulose have been used for haemorrhage control in thoracic surgery, abdominal surgery and neurosurgery. Oxidized resorbable cellulose (Gelita-cel) is a new haemostatic agent. Once saturated with blood, it swells and makes a gelatinous mass that formats as a fibrin clot. We have performed a prospective observational cohort study of patients operated for lung cancer or suspected lung cancer using Gelita-cel as a haemostatic agent. Between October 2010 and April 2012, 477 patients were operated in our department for lung cancer. Gelita-cel was used in 200 patients due to minor intraoperative haemorrhage after lymph node resection from Stations 2 to 11. During follow-up for lung cancer, computed tomography, which was performed 4-60 months after the primary operation, showed enlarged lymph nodes in the mediastinum in 16 patients. Endoscopic bronchial ultrasonographic biopsies of the lymph nodes showed foreign body material and granulomatous inflammation, and no sign of lung cancer recurrence. Gelita-cel has a high risk of causing granuloma and should not be used as a haemostatic agent in thoracic surgery.

OriginalsprogEngelsk
TidsskriftInteractive Cardiovascular and Thoracic Surgery
Vol/bind27
Udgave nummer6
Sider (fra-til)881-883
Antal sider3
ISSN1569-9293
DOI
StatusUdgivet - 1 dec. 2018

ID: 56416360